Almost every hydrogen product sold to consumers is something you drink. There is one clinical trial in the hydrogen literature that did something different: it put patients with psoriasis into a hydrogen-rich bath and scored their skin against a standard dermatology index[1]. The results were good enough to be worth reading carefully, and unusual enough that they do not transfer to a glass of hydrogen water.
This page covers what that trial found, what a hydrogen bath actually is, and why the delivery route is the entire point rather than an incidental detail.
Why bathing instead of drinking
Psoriasis is a skin disease. The tissue you want to reach sits at the surface of the body, and reactive oxygen species have been implicated in the disease process[1]. Drinking hydrogen water puts a small amount of dissolved gas into the gut, from which it distributes through the bloodstream to the whole body. Sitting in hydrogen-rich water puts the gas in direct and sustained contact with the affected tissue itself.
Hydrogen is a very small, uncharged molecule, which is the property that underpins most of the interest in it as a therapeutic gas[2]. Small and uncharged means it diffuses across membranes without needing a transporter. For a skin condition, that raises an obvious question: can you deliver it through the skin instead of the stomach? The bathing trial is the attempt to answer that.
What the trial did
The study enrolled patients with psoriasis and with parapsoriasis en plaques, a related chronic inflammatory skin condition[1]. It was a parallel-controlled trial, meaning patients were assigned to hydrogen-water bathing or to a control group and the two groups were compared directly. Outcomes were assessed at week 8.
The primary measure was the Psoriasis Area Severity Index, usually abbreviated PASI. PASI is the standard scoring instrument in psoriasis research. It combines how red, how thick and how scaly the lesions are with how much of the body surface they cover, producing a single number. Because it is standard, results scored in PASI can be compared against other treatments rather than existing in isolation.
Psoriasis trials conventionally report response rates rather than average score changes. A PASI 75 response means a patient’s score fell by at least 75 percent from baseline. PASI 50 means it fell by at least half. These thresholds are the currency of the field, and this trial reported both.
The results
At week 8, 24.4 percent of patients in the bathing group (10 of 41) achieved a PASI 75 response, against 2.9 percent (1 of 34) in the control group[1]. The odds ratio was 0.094 with a 95 percent confidence interval from 0.011 to 0.777, at a corrected p-value of 0.022.
At the PASI 50 threshold, 56.1 percent of the bathing group (23 of 41) responded, against 17.7 percent (6 of 34) in the control group, with an odds ratio of 0.168, a 95 percent confidence interval from 0.057 to 0.492, and p equal to 0.001[1].
Itch improved separately and strongly, at a p-value of 3.94 times ten to the negative fourth[1]. For a condition where itch drives a large share of the day-to-day misery, that is a clinically meaningful endpoint in its own right, not just a supporting number.
In the parapsoriasis en plaques group, 2 of 6 patients showed a complete response and 4 of 6 a partial response at week 8[1]. Six patients is a case series, not a trial arm, and the authors report it as such.
How to read those numbers honestly
The PASI 50 result is the more robust of the two, because it rests on 23 responders rather than 10, and its confidence interval is correspondingly tighter. The PASI 75 confidence interval runs from 0.011 to 0.777, which is wide. Wide intervals mean the true effect could be much larger or much smaller than the point estimate, and only that it is unlikely to be nothing.
There are three limitations that matter more than the effect size.
First, the trial is described as parallel-controlled rather than double-blind. Blinding a bath is genuinely hard: hydrogen is odourless and colourless, but a sham bath still needs to look and feel identical to patients and to whoever is scoring the skin. PASI scoring involves human judgement about redness and thickness, which is exactly the kind of endpoint that unblinded assessment can shift.
Second, this is a single trial. Psoriasis has a well-documented placebo response and a natural tendency to wax and wane, and neither of those is ruled out by one 8-week study.
Third, the comparison here is against a control bath, not against the drugs a dermatologist would actually prescribe. Nothing in this trial says hydrogen bathing performs comparably to topical steroids, phototherapy, or biologics, and nothing tested it in combination with them.
What the animal work adds
A separate study used an imiquimod-induced psoriasis model in mice to look at both the effect on skin lesions and the mechanism[3]. Mice bathed in hydrogen-rich water had lower psoriasis severity index scores than mice bathed in distilled water, at p less than 0.01.
On tissue examination, the distilled-water mice showed more abnormal keratosis, more thickening of the spinous layer, longer dermal processes and more Munro abscesses, which are the microscopic features pathologists look for in psoriasis[3]. The hydrogen-bathed mice had lower overall levels and lower peaks of interleukin-17, interleukin-23, tumour necrosis factor alpha, CD3 positive cells and malondialdehyde, all at p less than 0.05, and a lower peak level of proliferating cell nuclear antigen in the skin.
Those particular signalling molecules are not a random selection. The interleukin-17 and interleukin-23 axis is the pathway that modern psoriasis biologics were designed to block, so a bath that lowers both is at least acting on plausible biology rather than on nothing. Malondialdehyde is a marker of lipid peroxidation, which connects the finding back to the oxidative-stress rationale.
Mouse skin is not human skin, and an induced model is not the same disease as the chronic autoimmune condition. What the animal study does is make the human result less surprising. It does not confirm it.
What a hydrogen bath actually involves
Practically, a hydrogen bath means dissolving hydrogen gas into bathwater at a usable concentration and staying in it. That is not what a hydrogen water bottle or a magnesium tablet does. A single tablet is dosed for a glass of drinking water, and a bathtub holds on the order of a hundred times that volume, so scaling a drinking product up to bath volume is not a matter of adding a few more tablets.
Hydrogen also comes out of solution readily, and an open bath surface is a large area for it to escape from. Maintaining a concentration over a full bath is a harder engineering problem than maintaining one in a sealed bottle, and the research setups are built for it.
The honest summary is that this is a clinic protocol with promising early results, not a consumer product category. If you already own a hydrogen water device, it will not reproduce what was tested here.
If you have psoriasis
Psoriasis is a diagnosed medical condition with treatments that have far more evidence behind them than one 8-week bathing trial. Anyone with active disease should be working with a dermatologist, and nothing on this page is a reason to delay or stop a prescribed treatment.
The specific reason for caution is that psoriasis is associated with other conditions, including psoriatic arthritis, which can cause permanent joint damage if it is not treated. Substituting an unproven bath for effective treatment is not a neutral choice.
What the trial reasonably supports is asking a dermatologist about it as something additional, in a setting where the actual protocol can be reproduced, and where your PASI score is being tracked so you find out whether it is doing anything for you specifically.
The bottom line
Hydrogen-water bathing produced a real, statistically significant improvement in psoriasis severity and itch in one parallel-controlled trial, with a PASI 50 response in 56.1 percent of bathers against 17.7 percent of controls, supported by a mouse study showing reductions in the interleukin-17 and interleukin-23 signalling that drives the disease[1][3].
It is one unblinded trial, in a condition with a strong placebo response, testing a delivery route that no consumer hydrogen product reproduces. That combination makes it genuinely interesting research and a poor basis for buying anything.
References
- Positive effects of hydrogen-water bathing in patients of psoriasis and parapsoriasis en plaques. Scientific Reports, 2018
- Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine, 2007
- Effect and mechanism of hydrogen-rich bath on mice with imiquimod-induced psoriasis. Experimental Dermatology, 2023
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
